EverSource Wealth Advisors’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
LGM
GP
EverSource Wealth Advisors's BNTX Position: Q2 2026 in Review
EverSource Wealth Advisors reduced its BioNTech (BNTX) stake by 56% in Q2 2026, selling an estimated $9.41K and leaving 77 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #3101.
EverSource Wealth Advisors first reported a position in BNTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $92.9K in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.
- EverSource Wealth Advisors held 77 shares of BioNTech worth $7.17K as of Q2 2026.
- EverSource Wealth Advisors sold 100 BioNTech shares in Q2 2026, an estimated $9.41K.
- BioNTech made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3101 holding.
- EverSource Wealth Advisors first reported a position in BioNTech in Q2 2022 and has held it in 16 quarters since.
- EverSource Wealth Advisors's BioNTech position peaked at $92.9K in Q3 2023.
- 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.
Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.